Ogawa Makoto | Biomedical Research Center Osaka University Medical School
スポンサーリンク
概要
関連著者
-
HAMAOKA TOSHIYUKI
Biomedical Research Center, Faculty of Medicine, Osaka University
-
HAMAOKA Toshiyuki
Department of Oncology (C6), Osaka University Graduate School of Medicine
-
Fujiwara H
Department Of Oncology Osaka University Graduate School Of Medicine
-
Fujiwara Hiromi
Department Of Oncology (c6) Graduate School Of Medicine Osaka University
-
FUJIWARA Hiromi
Biomedical Research Center, Osaka University Medical School
-
Fujiwara H
Osaka Univ. Osaka Jpn
-
WIJESURIYA Rishani
Department of Oncology, Biomedical Research Center, Osaka University Graduate School of Medicine
-
ZOU Jian-Ping
Biomedical Research Center, Osaka University Medical School
-
OGAWA Makoto
Biomedical Research Center, Osaka University Medical School
-
WIJESURIYA Rishani
Biomedical Research Center, Osaka University Medical School
-
Hamaoka Toshiyuki
Department Of Oncology (c6) Osaka University Graduate School Of Medicine
-
Hamaoka Toshiyuki
Biomedical Research Center Faculty Of Medicine Osaka University
-
Hamaoka Toshiyuki
Biomedical Research Center Osaka University Medical School
-
Zou Jian-ping
Biomedical Research Center Osaka University Medical School
-
Fujiwara Hiromi
Biomedical Research Center Osaka University Medical School
-
Fujiwara H
Department Of Oncology (c6) Graduate School Of Medicine Osaka University
-
Fujiwara Hiromi
Department Of Oncology Osaka University Graduate School Of Medicine
-
Hamaoka Toshiyuki
Department Of Oncology Osaka University Graduate School Of Medicine
-
Ogawa Makoto
Biomedical Research Center Osaka University Medical School
-
Fujiwara H
Department Of Oncology Biomedical Research Center Osaka University Graduate School Of Medicine
-
Wijesuriya Rishani
Department Of Oncology Biomedical Research Center Osaka University Graduate School Of Medicine
-
Ono Shiro
Division Of Oncogenesis Department Of Oncology Biomedical Research Center Osaka University Graduate
-
Yu Wen-gong
Department Of Oncology Biomedical Research Center Osaka University Graduate School Of Medicine
-
YU Wen-Gong
Biomedical Research Center, Osaka University Medical School
-
UMEHARA Kazunari
Biomedical Research Center, Osaka University Medical School
-
ONO Shiro
Biomedical Research Center, Osaka University Medical School
-
Ono Shiro
Department Of Oncology (c6) Graduate School Of Medicine Osaka University
-
Umehara Kazunari
Biomedical Research Center Osaka University Medical School
-
TAI Xu-Guang
Department of Oncology, Osaka University Graduate School of Medicine
-
Tai Xu-guang
Department Of Oncology Osaka University Graduate School Of Medicine
-
MARUO Seiji
Biomedical Research Center, Osaka University Medical School
-
YAMAMOTO Norihiko
Biomedical Research Center, Osaka University Medical School
-
TAI Xu-Guang
Biomedical Research Center, Osaka University Medical School
-
Maruo Seiji
Biomedical Research Center Osaka University Medical School
-
IWASAKI Masayuki
Biomedical Research Center, Osaka University Medical School
-
TAKENAKA Hiroshi
Biomedical Research Center, Osaka University, Medical School
-
MU Jie
Biomedical Research Center, Osaka University, Medical School
-
TSUTSUI Tateki
Biomedical Research Center, Osaka University, Medical School
-
YOSHIDA Ryotaro
0saka Bioscience Institute
-
HERRMANN Steven
Genetics Institute
-
Iwasaki Masayuki
Department Of Oncology Biomedical Research Center Osaka University Graduate School Of Medicine
-
YAMASHITA Motozo
Biomedical Research Center, Osaka University Medical School
-
MU Jie
Department of Oncology, Biomedical Research Center
-
Yamashita Motozo
Biomedical Research Center Osaka University Medical School
-
Mu Jie
Department Of Oncology Biomedical Research Center
-
Takenaka Hiroshi
Biomedical Research Center Osaka University Medical School
-
Tsutsui Tateki
Department Of Oncology Biomedical Research Center
-
Yamamoto Norihiko
Biomedical Research Center Osaka University Medical School
著作論文
- MOLECULAR MECHANISMS UNDERLYING T CELL MIGRATION RESPONSIBLE FOR IL-12-INDUCED TUMOR REGRESSION
- Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12
- B cell-mediated down-regulation of IFN-γ and IL-12 Production induced during antitumor immune responses in the tumorbearing state